Cardiovascular series

Cardiovascular and cerebrovascular diseases are a collective term for conditions affecting the heart, blood vessels, and brain, broadly referring to ischemic or hemorrhagic disorders of the heart, brain, and other bodily tissues caused by factors such as hyperlipidemia, thickened blood, atherosclerosis, and hypertension. These diseases pose a serious threat to human health, particularly among middle-aged and elderly individuals over 50, and are characterized by high incidence rates, high disability rates, and significant mortality. Even with access to the most advanced and comprehensive treatment options available today, more than 50% of stroke survivors still struggle to fully regain independence in their daily lives. Globally, cardiovascular and cerebrovascular diseases claim approximately 15 million lives each year, making them the leading cause of death worldwide.

Psychiatry series

Neurological disorders include cerebrovascular diseases, periodic paralysis, progressive muscular dystrophy, myotonic dystrophy, and ataxia. Commonly used medications include huperzine A injection and flunarizine hydrochloride capsules, among others.

Hepatobiliary, Gastroenterology Series

Liver and biliary, as well as digestive system diseases, include: gastroesophageal reflux disease, esophageal cancer, gastritis, peptic ulcers, stomach cancer, inflammatory bowel disease, alcoholic liver disease, cirrhosis, primary liver cancer, hepatic encephalopathy, pancreatitis, pancreatic cancer, and gastrointestinal bleeding, among others. Commonly used medications include: 1. Acid-reducing drugs and treatments for gastritis and peptic ulcers, such as cimetidine tablets and omeprazole enteric-coated capsules; 2. Digestive aids like Jianpi Syrup; 3. Anti-emetics; 4. Laxatives; 5. Antidiarrheals; 6. Medications for liver and biliary disorders, such as bifendate drops.

Pediatric Series

From the perspective of the total number of affected individuals, the pediatric drug market holds significant untapped potential. Notably, approximately 85% of children suffer from respiratory and digestive system diseases—conditions that not only account for the largest proportion of pediatric illnesses but also tend to occur frequently and often recur. Looking at the age distribution of patients discharged in 2012, intestinal infectious diseases, upper respiratory tract infections, lower respiratory tract infections (such as pneumonia), and influenza collectively accounted for 65%, 79.7%, 75.5%, and 66.9% of children, respectively. As a well-known pediatric brand and trusted expert in pediatric medications, the Hailongwa series is dedicated to providing comprehensive care for your child’s health!

Gynecology Series

Gynecological medications refer to a general term for drugs used to prevent, diagnose, and treat gynecological conditions. The primary form of these medications is oral administration. Based on their indications, oral gynecological drugs can be specifically categorized into three main types: those for gynecological inflammation, those targeting gynecological blood stasis, and those used for dysmenorrhea—among which medications for gynecological inflammation account for more than 40%. Since gynecological conditions often require long-term treatment, traditional Chinese medicines (TCMs) play a crucial role in managing these diseases due to their low cost and minimal side effects. As a result, TCMs hold a clear advantage in the market for oral gynecological medications. Calcium citrate, a new-generation, eco-friendly organic calcium supplement, is specially formulated for pregnant women and their babies. Additionally, Tongjingning—a clinically proven first-choice medication for treating dysmenorrhea—has demonstrated remarkable efficacy in alleviating menstrual pain. Gynecological Medication One – Shengji Huahua Granules – Tongjingning Granules – Yimu Granules Gynecological Medication No. 2 – A Gui Nourishing Blood & Sugar Syrup – Nourishing Blood & Calming Spirit Syrup Internal Medicine Medications – Compound Angelica Injection

Respiratory series

Respiratory diseases—including asthma, bronchitis, chronic obstructive pulmonary disease (COPD), cor pulmonale, and tuberculosis (excluding lung cancer)—rank as the fourth leading cause of death in urban areas (accounting for 13.1%) and the third in rural regions (16.4%). In recent years, the incidence of respiratory illnesses has risen significantly, driven by factors such as air pollution, smoking, exposure to physicochemical and biological agents linked to industrial growth, and the aging population. Notably, COPD remains alarmingly prevalent, affecting more than 8% of individuals aged 40 and older. Commonly prescribed medications include: 1) antibiotics—such as penicillins, cephalosporins, quinolones, and macrolides; 2) bronchodilators—like compound clenbuterol and bromhexine capsules; 3) expectorants—such as bromhexine; 4) cough suppressants; 5) corticosteroids; and 6) anti-tuberculosis drugs, including isoniazid.

Anti-infective Drug Series

Anti-infective drugs refer to antibiotics, sulfonamides, quinolones, and other chemically synthesized medications (such as isoniazid, metronidazole, nitrofurantoin, pipemidic acid, etc.) that possess the ability to kill or inhibit a wide range of pathogenic microorganisms. These drugs can be administered systemically through oral, intramuscular, or intravenous routes.

Other series

Wanbande Pharmaceutical Group has established "Joint Laboratories" and product development platforms in collaboration with prestigious pharmaceutical research institutes, including the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences, Zhejiang University, Zhejiang University of Technology, and China Pharmaceutical University. Leveraging its distinct regional advantages in active pharmaceutical ingredient (API) production and a robust product pipeline, Wanbande is focusing on over 10 high-quality APIs and formulations, actively optimizing their manufacturing processes and enhancing quality standards to develop unique, differentiated products—many of which have already been patented for protection. By integrating API production with formulation expertise, Wanbande has cultivated a core portfolio of patented, premium-quality pharmaceuticals. Capitalizing on the opportunities presented by the "Consistency Evaluation" initiative, the company is poised to strengthen and expand its presence in the "boutique generic drug" market, solidifying Wanbande's position as a leader in high-quality, widely-used pharmaceuticals. Gastrointestinal and Metabolic Drugs - Vitamin C Injection - Vitamin B1 Injection - Vitamin B6 Injection Musculoskeletal System Medications – Sodium Diclofenac Enteric-Coated Tablets – Ciprobay Tablets, Ibuprofen Tablets Medications for the Blood and Hematopoietic System - Aspirin Enteric-Coated Tablets - Inosine Oral Solution - Etamsylate Injection - Vitamin B12 Injection - Adrenochrome Injection Neurological Medications – Nefopam Hydrochloride Tablets, Analgin Tablets – Aminophenazone Tablets – Isopropylpyronil Fumarate Tablets – Nefopam Hydrochloride Injection – Benzyl Alcohol Injection – Procaine Hydrochloride Injection – Compound Lidocaine Hydrochloride Injection – Compound Aminopyrine-Barbiturate Injection Internal Medicine Medications – Huoxiang Zhengqi Water – Shi Di Shui – Xiao Shan Oral Liquid – Chaihu Injection Topical medications for skin conditions – Iodine tincture Miscellaneous – Balanced Salt Irrigation Solution

Large Infusion Series

Active Pharmaceutical Ingredient Series 0

Refers to raw pharmaceutical materials used in the production of various dosage forms—they are the active ingredients within these formulations. These include chemically synthesized substances, plant extracts, or biotechnologically produced powders, crystals, and extracts designed for medicinal use, though they cannot be administered directly to patients.

Large Infusion Series 2

Large-volume parenterals, commonly known as "large infusions" (LVP), refer to sterile liquid preparations with a volume of 50 ml or more, administered directly into the body via intravenous drip. Based on their clinical applications, large-volume infusions can be broadly categorized into five types: fluid-balancing solutions, nutritional solutions, blood-volume-expanding infusions, therapeutic drug-infusion products, and dialysis/contrast agents. Since their introduction in clinical practice, infusion product packaging has evolved through three distinct generations. Currently, the primary packaging materials available in China’s infusion market include glass bottles, plastic bottles, non-PVC flexible bags, and upright flexible bags. Among these, non-PVC flexible bag technology stands out as both safe and effective, meeting stringent pharmaceutical and environmental standards—and it is widely recognized as the key direction for future advancements in large-volume infusion packaging technology.

Small-volume injectables

Small-volume injectables are products manufactured through steps including raw and excipient preparation, formulation, filling, sealing, sterilization, quality control, and packaging.

Huabao Tong Series

Active Pharmaceutical Ingredient Series